Tag: STEMI
STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns
Patients with ST-elevation myocardial infarction (STEMI) occurring during the first COVID-19 loc...
Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI
Vesalio recently announced the start of enrolment in its NATURE study using enVast, the company’s fi...
Miracor Medical’s PiCSO System receives CE mark
Miracor Medical has announced the award of the CE mark for its latest generation of PiCSO Impuls...
Using telemedicine to transform the management of acute myocardial infarction: the Latin America telemedicine infarct network (LATIN) experience
Telemedicine has come into its own during the pandemic. Sameer Mehta details the STEMI treatment...
Does your insurance card matter when you have a heart attack?
Medicaid reimbursement to healthcare facilities on ST-elevation myocardial management—or STEMI, a se...
ESC 2017: Further decreasing mortality after STEMI will be difficult
According to results from the FAST-MI programme, six-month mortality after ST-segment elevation ...
The ATI score: A new tool to triage novel treatments in patients with myocardial infarction
Mechanical reperfusion via primary percutaneous coronary intervention (PCI) in combination with ...
Performing PCI in comatose survivors of cardiac arrest
Because of a significant improvement in the prehospital treatment of patients with out-of-hospit...
Infection in the setting of STEMI
The association between infections and acute coronary syndromes has been the subject of interest...
CADILLAC risk score could be used to identify STEMI patients for safe, early discharge
Musa A Sharkawi (Department of Cardiovascular Medicine, Hartford Hospital, Hartford, USA) and ot...
Smartphones can help to streamline hospital transfer for myocardial infarction patients
A study published, as a research letter, in the Journal of the American College of Cardiology indica...
ESC 2016: Off-hours STEMI patients do not have worse outcomes
A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve o...
ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents
The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-el...
